ADAR1 Capital Management »

Si-bone shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Si-bone (SIBN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Si-bone

Tip: Access up to 7 years of quarterly data

All positions including Si-bone held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Si-bone by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $159k 13k 12.63

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Si-bone

First Light Asset Management
BlackRock
Vanguard Group
American Century Companies
Brown Advisory Holdings Incorporated
Cadian Capital Management
Vanguard Capital Management
Impax Asset Management Group
Silvercrest Asset Management Group
Nuveen
State Street Corporation
Geode Capital Management
Granahan Investment Management
Champlain Investment Partners
Point72 Asset Management

View all funds holding Si-bone